3 unknown, 2 completed, 1 recruiting, 1 terminated. 3 Phase 3, 2 Phase 4, 1 Not applicable, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Unknown 2, Completed 1 |
| Phase 4 | 2 | Terminated 1, Unknown 1 |
| Not applicable | 1 | Completed 1 |
| Phase 2 | 1 | Recruiting 1 |
Follow Bleeding Esophageal Varices: new trials by email Literature Review of Bleeding Esophageal Varices trials Research Report on Bleeding Esophageal Varices
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Prophylactic Endoscopic Variceal Ligation in Patients With High-risk Esophageal Varices Receiving Atezo/Bev for HCC Endoscopic variceal ligation (EVL) - Hepatocellular Carcinoma, Esophageal Varix | Phase 2 | Recruiting | Asan Medical Center | 44 | 2025-05-28 | 2025-07-24 |
| Comparison of 24-hours Versus 72-hours of Octreotide Infusion in Preventing Early Rebleed From Esophageal Varices Octreotide - Esophageal Varices, Liver Cirrhoses | Phase 4 | Terminated | Medical University of South Carolina | 34 | 2018-09-19 | 2025-11-20 |
| Endoscopic Injection Sclerotherapy Versus N-butyl-2-cyanoacrylate Injection Injection Sclerotherapy, N-butyl-2-cyanoacrylate - Bleeding Esophageal Varices | Phase 3 | Unknown | Sherief Abd-Elsalam | 113 | 2016-01-01 | 2018-04-24 |
| TIPS for Variceal Rebleeding in Cirrhotic Patients With Occlusive Portal Vein Thrombosis and CTPV TIPS, Propranolol, Endoscopic therapy - Portal Vein, Cavernous Transformation of, Portal Vein Thrombosis | Phase 3 | Unknown | Zaibo Jiang | 100 | 2015-07-01 | 2016-08-03 |
| Prognostic Value of Measuring DsAz by MRI in Cirrhotic Patients on Prophylactic Treatment With β Blocker (AzyMR) azygos blood flow measurements by MRI - Bleeding Esophageal Varices, Cirrhosis | Not applicable | Completed | University Hospital, Angers | 71 | 2014-10-01 | 2020-12-24 |
| Efficacy of Statin Association With Standard Treatment in Prevention of Recurrent Hemorrhage in Patient With Cirrhosis and Variceal Bleeding Simvastatin, Placebo - Cirrhosis, Hypertension, Portal | Phase 3 | Completed | Juan A. Arnaiz | 150 | 2010-11-01 | 2015-03-19 |
| Primary Prevention of Patients With Hepatocellular Carcinoma and Concomitant Esophageal Varices Propranolol, Esophageal variceal ligation - Bleeding Esophageal Varices, Hepatocellular Carcinoma | Phase 4 | Unknown | Taipei Veterans General Hospital, Taiwan | 200 | 2009-08-01 | 2019-08-30 |
Carcinoma, Hepatocellular (2) · Esophageal and Gastric Varices (2) · Fibrosis (2) · Hypertension, Portal (2) · Gastrointestinal Hemorrhage (1) · Liver Cirrhosis (1) · Portal Vein, Cavernous Transformation Of (1)
Digestive System Diseases (5) · Liver Diseases (5) · Pathologic Processes (4) · Pathological Conditions, Signs and Symptoms (4) · Adenocarcinoma (2) · Carcinoma (2) · Digestive System Neoplasms (2) · Esophageal Diseases (2) · Gastrointestinal Diseases (2) · Hypertension, Portal (2) · Liver Neoplasms (2) · Neoplasms (2) · Neoplasms by Histologic Type (2) · Neoplasms by Site (2) · Neoplasms, Glandular and Epithelial (2)
Propranolol (2) · Enbucrilate (1) · Octreotide (1) · Portasystemic Shunt, Transjugular Intrahepatic (1) · Simvastatin (1) · Warfarin (1) · ethanolamine oleate (1)
Asan Medical Center (1) · Juan A. Arnaiz (1) · Medical University of South Carolina (1) · Sherief Abd-Elsalam (1) · Taipei Veterans General Hospital, Taiwan (1) · University Hospital, Angers (1) · Zaibo Jiang (1)
China (1) · Egypt (1) · France (1) · South Korea (1) · Spain (1) · Taiwan (1) · United States (1)
Don Rockey, M.D (1) · Jaume Bosch, MD (1) · Jihyun An, MD, PhD (1) · Ming-Chih Hou, MD (1) · Mohamed Abdelraouf, MD (1) · Mohamed Alsebaey, MD (1) · Sherief Abd-Elsalam, MD (1) · Zaibo Jiang (1)
PMID 19097774, PMID 26774179, PMID 30717684, PMID 34902530, PMID 34912612, PMID 35944830, PMID 36254617, PMID 37199193, PMID 38123994, PMID 38438359, PMID 38798717, PMID 39241828, PMID 39687040
2009 (1)